Prestige Consumer Healthcare Inc. (PBH) News
Filter PBH News Items
PBH News Results
|Loading, please wait...|
PBH News Highlights
- 500 - Internal server error
- Over the past 3 days, the trend for PBH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about PBH are EYE, MDT and BC.
Latest PBH News From Around the Web
Below are the latest news stories about Prestige Consumer Healthcare Inc that investors may wish to consider to help them evaluate PBH as an investment opportunity.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Prestige Brand Holdings (PBH) and uniQure (QURE)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT), Prestige Brand Holdings (PBH) and uniQure The post Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Prestige Brand Holdings (PBH) and uniQure (QURE) appeared first on Smarter Analyst .
Acquisition adds TheraTears brand to Company’s leading eye care portfolioAcquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basisTransaction expected to close during fiscal 2Q TARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC (“Akorn”) for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA of ~$20 million equating to a transaction valued at less than 10x pro-forma EBIT...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
How far off is Prestige Consumer Healthcare Inc. ( NYSE:PBH ) from its intrinsic value? Using the most recent financial...
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 fourth quarter and year-end earnings release on Thursday, May 6, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 5996287. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. Telephonic replays will be available for approximately one week following completion of the live call and can be acc...
EYE DROPS AND LUBRICANTS MARKET 2020 INDUSTRY INSIGHTS AND FOREMOST PLAYERS ARE AKORN CONSUMER HEALTH (THERATEARS), ALLERGAN PLC, JOHNSON & JOHNSON, NOVARTIS INTERNATIONAL AG (ALCON INC.), PFIZER INC., PRESTIGE CONSUMER HEALTHCARE INC.
The Global Eye Drops and Lubricants Market research report offers an in-depth analysis of the global market, providing relevant information for the new market entrants or well-established players. Some of the key strategies employed by leading key players operating in
TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third…